In a festive atmosphere of solidarity, Genoma Running Team participated today in the Pink Ribbon Challenge with a view to promoting breast cancer prevention.
The 14 km race took place in Thonon-les-Bains, France, on the south shore of Lake Geneva. The goal of this event was to spread a preventive message, remember how important it is to take care of your body and raise awareness on early screening.
Women need to know for a fact that early detection saves lives. Breast cancer, if identified at an early stage, can be cured in more than 90% of cases, and also be treated with less aggressive therapy.
“Serenity” was written on all the pink t-shirts of Genoma’s team: this is not only a message of care and solidarity, but also the name of a genetic screening test that can be used for women of any age to detect mutations of BRCA1 and BRCA2 genes.
BRCA1 and BRCA2 (Breast Cancer 1 and 2) are tumor suppressor genes that help to ensure the stability of the cell’s genetic material. When either of these genes undergoes a mutation, DNA damage cannot be repaired properly, and cells are more likely to develop additional genetic alterations resulting in cancer. Knowing this in advance, appropriate action can be taken to preserve your health.
In conclusion, the more women screened for BRCA1 and BRCA2 mutations, the greater the number of lives that are saved. And congratulations to Genoma that ranked eighth in the competition!